March
29,
2022
Kremers Lecture Hosted by Rho Chi and Phi Lambda Sigma
Julie A. Johnson, PharmD
Dean & Distinguished Professor
University of Florida College of Pharmacy
Efficacy and side effects of many of the most commonly used drugs are influenced by genetic variability. This presentation will address some of the most advanced examples and the work being done to document the benefit on clinical outcomes of genotype guided approaches to drug therapy decision-making in the clinical practice setting.
Julie Johnson is Dean of the University of Florida College of Pharmacy and Distinguished Professor of Pharmacy and Medicine (Cardiovascular Medicine). She received her BS in Pharmacy from the Ohio State University and her PharmD from the University of Texas at Austin and the UT Health Science Center at San Antonio. She completed a post-doctoral fellowship in cardiovascular pharmacology/ pharmacokinetics at Ohio State.
Dr. Johnson’s research focuses on cardiovascular pharmacogenomics and implementation of precision medicine approaches into clinical practice. She is an internationally-recognized leader in pharmacogenomics and genomic medicine, with over 300 peer reviewed publications and over $50M in research funding as principal investigator. In 2015, 2016, 2017 and 2018 she was named a Clarivate Analytics Highly Cited Researcher, indicating she was in the top 1% most highly cited scientists globally in the previous decade.
Under her leadership as dean, the UF College of Pharmacy implemented a new PharmD curriculum, its faculty grew by 90%, the US News and World Report ranking rose from #14 to #5, research funding grew 3.3-fold and research funding rankings rose from the high teens to #3, and it has the highest percentage of under-represented minority students among professional degree programs at UF and top 40 colleges of pharmacy.
Dr. Johnson has had numerous service roles, including with the NIH, FDA, CDC, American Heart Association, American College of Clinical Pharmacy (ACCP) and ASCPT, for which she served as President in 2016-17.
Dr. Johnson has received numerous awards. She was elected to the National Academy of Medicine, and was inducted as a Fellow of the American Association for the Advancement of Science, along with fellowship in three other societies. She has been the recipient of the Leon I Goldberg Young Investigator Award from the ASCPT, Volwiler Research Achievement Award from the American Association of Colleges of Pharmacy (AACP) (2007), the Therapeutic Frontiers Award, and Paul Parker Medal from ACCP, the ASCPT Rawls Palmer Progress in Medicine Award, the PMWC Luminary Award, among others. She has also received teaching awards from both the University of Tennessee and the University of Florida.
